Association between GPx1 Pro198Leu polymorphism, GPx1 activity and plasma selenium concentration in humans

被引:78
|
作者
Jablonska, E. [1 ]
Gromadzinska, J. [1 ]
Reszka, E. [1 ]
Wasowicz, W. [1 ]
Sobala, W. [2 ]
Szeszenia-Dabrowska, N. [2 ]
Boffetta, P. [3 ]
机构
[1] Nofer Inst Occupat Med, Dept Toxicol & Carcinogenesis, PL-91348 Lodz, Poland
[2] Nofer Inst Occupat Med, Dept Epidemiol, PL-91348 Lodz, Poland
[3] Int Agcy Res Canc, F-69372 Lyon, France
关键词
Glutathione peroxidase; Selenium; Genetic polymorphism; Humans; GLUTATHIONE-PEROXIDASE; ALCOHOL-CONSUMPTION; BREAST-CANCER; RISK; GENE;
D O I
10.1007/s00394-009-0023-0
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Glutathione peroxidase 1 (GPx1) is an antioxidant selenoenzyme that protects the cells against reactive oxygen species. Its activity depends on the concentration of selenium (Se) which is present in the active centre of the enzyme. The genetic polymorphism of GPx1 encoding gene (GPx1) associated with the proline (Pro) to leucine (Leu) change at codon 198 is supposed to be functional. An in vitro study performed on human breast carcinoma cell line showed that GPx1Leu allele was associated with a lower responsiveness of the enzyme to Se added to the culture medium. Some authors observed a decrease in GPx1 activity associated with GPx1 Leu allele in humans; however, there were no findings on how GPx1 activity changes with Se concentration in individuals with different GPx1 genotypes. To assess whether GPx1 activity that depends on the Se status may be influenced by GPx1 polymorphism through studying this relationship in the blood of healthy individuals. The association between the Se status, GPx1 activity and GPx1 genotype was assessed in 405 individuals of Polish origin. GPx1 activity in red blood cells was measured by the spectrophotometric method by Paglia and Valentine, using t-butylhydroperoxide as the substrate. Plasma Se concentration was measured using graphite furnace atomic absorption spectrometry. GPx1 Pro198Leu polymorphism was determined with the Molecular Beacon Real-Time PCR assay. In the subjects examined, the mean plasma Se concentration was 54.4 +/- A 14.2 mcg/L. The mean GPx1 activity was 15.1 +/- A 4.7 U/g Hb. No difference regarding both the parameters was found between individuals with different GPx1 genotype. However, the association between GPx1 activity and Se concentration, analyzed separately for each genotype group, was not the same. The correlation coefficients amounted to r = 0.44 (p < 0.001) for Pro/Pro, r = 0.35 (p < 0.001) for Pro/Leu and r = 0.25 (p = 0.45) for Leu/Leu group, which indicates that the correlation strength was as follows: Pro/Pro > Pro/Leu > Leu/Leu. Notably, statistically significant difference in this relationship (analyzed as difference between correlation coefficients for linear trends) was found between genotypes Pro/Pro and Leu/Leu (p = 0.034). The findings of the present study provide evidence for the hypothesis based on in vitro studies which assumes that GPx1 Pro198Leu polymorphism has a functional significance for the human organism and that this functionality is associated with a different response of GPx1 activity to Se. They also point to the importance of the genetic background in the assessment of the Se status with the use of selenoprotein biomarkers such as GPx1 activity.
引用
收藏
页码:383 / 386
页数:4
相关论文
共 50 条
  • [1] Association between GPx1 Pro198Leu polymorphism, GPx1 activity and plasma selenium concentration in humans
    E. Jablonska
    J. Gromadzinska
    E. Reszka
    W. Wasowicz
    W. Sobala
    N. Szeszenia-Dabrowska
    P. Boffetta
    European Journal of Nutrition, 2009, 48 : 383 - 386
  • [2] Association Between GPX1 Pro198Leu Polymorphism and the Risk of Gastric Cancer
    Gigasari, Masoumeh Khani
    Salehi, Zivar
    Saedi, Hamid Saeidi
    DIGESTIVE DISEASES AND SCIENCES, 2015, 60 (09) : 2557 - 2557
  • [3] Associations between GPX1 Pro198Leu polymorphism and erythrocyte GPX activity and risk of colorectal cancer
    Hansen, R. D.
    Krath, B.
    Sorensen, M.
    Loft, S.
    Tjonneland, A.
    Overvad, K.
    EPIDEMIOLOGY, 2007, 18 (05) : S107 - S107
  • [4] No association between GPX1 Pro198Leu and breast cancer risk
    Cox, DG
    Hankinson, SE
    Kraft, P
    Hunter, DJ
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2004, 13 (11) : 1821 - 1822
  • [5] Evaluation of GPx1 Pro198Leu polymorphism in idiopathic male infertility
    M. A. Mazjin
    Z. Salehi
    F. Mashayekhi
    M. Bahadori
    Molecular Biology, 2016, 50 : 77 - 80
  • [6] Evaluation of GPx1 Pro198Leu Polymorphism in Idiopathic Male Infertility
    Mazjin, M. A.
    Salehi, Z.
    Mashayekhi, F.
    Bahadori, M.
    MOLECULAR BIOLOGY, 2016, 50 (01) : 77 - 80
  • [7] GPX1 Pro198Leu polymorphism and breast cancer risk: a meta-analysis
    Jia Hu
    Guo-Wu Zhou
    Ning Wang
    Ya-Jie Wang
    Breast Cancer Research and Treatment, 2010, 124 : 425 - 431
  • [8] RELATIONSHIP BETWEEN GPX1 PRO198LEU POLYMORPHISM AND SUSCEPTIBILITY OF KASHIN-BECK DISEASE
    Xiong, Y. M.
    Zou, X. Z.
    Chen, Q.
    Du, X. L.
    Liu, J. R.
    VALUE IN HEALTH, 2015, 18 (07) : A638 - A638
  • [9] GPX1 Pro198Leu polymorphism, erythrocyte GPX activity, interaction with alcohol consumption and smoking, and risk of colorectal cancer
    Hansen, Rikke Dalgaard
    Krath, Britta Naimi
    Frederiksen, Kirsten
    Tjonneland, Anne
    Overvadd, Kim
    Roswall, Nina
    Loft, Steffen
    Dragsted, Lars Ove
    Vogel, Ulla
    Raaschou-Nielsen, Ole
    MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS, 2009, 664 (1-2) : 13 - 19